YHLO

Call Directions Website Contact the business

YHLO Focus on healthcare, better life with technology In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers.

15/10/2026

YHLO Expert Insights | Turning Research into Patient Benefits 🌐

Scientific progress depends on continued learning, collaboration, and improvement.

Prof. Syed Atiqul Haq highlights the importance of collaboration between academia and industry in advancing research, addressing unmet needs, and helping translate scientific findings into practical benefits for patients. 💬

He also underscores the value of making these advances accessible across different healthcare settings and regions.

🎥 Watch his insights on the role of collaboration in advancing rheumatology.
📢 The full-length interview will be coming soon.

🔗 Learn more about YHLO: https://en.szyhlo.com

14/10/2026

YHLO Expert Insights | Why Does Early Diagnosis Matter? 🤔

For people with rheumatoid arthritis, time matters.

Prof. Syed Atiqul Haq highlights a key challenge: delays in accessing rheumatology care can make timely diagnosis and treatment difficult.
He emphasises the need for better diagnostic technologies alongside improvements in healthcare systems and management.

Earlier diagnosis requires more than technology alone — access to care matters, too.

🎥 Hear his perspective in this short interview.
📢 The full-length interview will be coming soon.

🔗 Learn more about YHLO: https://en.szyhlo.com

Looking Beyond Bone Density in Bone Health Management 🚀 Bone health is influenced by a complex balance of mineral metab...
14/10/2026

Looking Beyond Bone Density in Bone Health Management 🚀

Bone health is influenced by a complex balance of mineral metabolism, hormones, and bone turnover. Understanding these factors can provide valuable information when assessing osteoporosis and other metabolic bone diseases.

The YHLO Bone Metabolism Solution brings together 25-OH Vitamin D, PTH, Calcitonin, and Osteocalcin, providing complementary information to support bone health management and assist the differential diagnosis of osteoporosis and metabolic bone diseases.

By combining multiple markers, YHLO supports a broader laboratory approach to understanding bone metabolism and monitoring bone health. 📈

🔗 Learn more about YHLO products: https://en.szyhlo.com/products/Analyzers.html

13/10/2026

YHLO Expert Insights | How Far Has Rheumatology Come? 🌐

“Faster than our imagination.”

Looking back over the past decades, Prof. Syed Atiqul Haq reflects on the remarkable progress in rheumatology — from the treatment approaches of the 1990s to the possibility of drug-free remission for some patients today.

Advances in diagnosis and treatment have changed the outlook for many people living with rheumatic diseases.

🎥 Watch this expert insight, and stay tuned for more.
📢 The full-length interview will be coming soon.

🔗 Learn more about YHLO: https://en.szyhlo.com

YHLO Expert Insights | Coming Soon 🎥 What does the future of rheumatology and autoimmune care look like? 🤔 Through YHLO ...
12/10/2026

YHLO Expert Insights | Coming Soon 🎥

What does the future of rheumatology and autoimmune care look like? 🤔

Through YHLO , we bring together voices from the medical community to share perspectives on disease management, diagnostic advances, and the evolving needs of patients.

In our first conversation, Prof. Syed Atiqul Haq, Professor of Rheumatology from Bangladesh, shares his insights on the progress of rheumatology, the importance of early diagnosis, and the role of collaboration in advancing autoimmune care.

Stay tuned for expert perspectives coming soon.

🔗 Learn more about YHLO: https://en.szyhlo.com

Building a More Comprehensive RA Testing Panel 🩺 Rheumatoid arthritis assessment may require different serological mark...
12/10/2026

Building a More Comprehensive RA Testing Panel 🩺

Rheumatoid arthritis assessment may require different serological markers depending on the clinical context.

YHLO brings together Anti-CCP, RF, RF IgM, RF IgG, and RA33 IgG in one rheumatoid arthritis diagnostics portfolio, helping laboratories expand their testing coverage and provide complementary information for RA assessment. 📌

The portfolio supports early RA detection, broader serological assessment, differential diagnosis, and testing coverage for seronegative and atypical RA.

Which markers are part of your routine RA testing strategy? 💬

Discover more about YHLO Rheumatoid Arthritis Diagnostics in the poster. 👇

🔗 Learn more about YHLO: https://en.szyhlo.com

For people living with arthritis, movements we often take for granted can become difficult. This World Arthritis Day, le...
12/10/2026

For people living with arthritis, movements we often take for granted can become difficult.

This World Arthritis Day, let's look beyond the condition and focus on what matters most — helping people keep moving forward.

Know earlier. Act sooner. Move better. 🔬

🔗 Learn more about YHLO: https://en.szyhlo.com

Could Earlier Detection Make a Difference in Rheumatoid Arthritis? 💬 📌 Rheumatoid arthritis (RA) is a chronic autoimmun...
11/10/2026

Could Earlier Detection Make a Difference in Rheumatoid Arthritis? 💬

📌 Rheumatoid arthritis (RA) is a chronic autoimmune disease that can progressively affect the joints, making early recognition important for timely clinical intervention.

A broader serological assessment can provide complementary information when RA is suspected. YHLO's rheumatoid arthritis diagnostics bring together Anti-CCP, RF, RF IgM, RF IgG, and RA33 IgG, supporting a more comprehensive approach to RA assessment.

By bringing multiple autoimmune markers into the laboratory workflow, YHLO supports clinicians with additional information when evaluating patients with suspected rheumatoid arthritis.

What kinds of autoimmune markers are used in your approach to RA assessment? 🤔

🔗 Learn more about YHLO: https://en.szyhlo.com

Celebrating China's National Day🎉 October 1 marks the National Day of the People's Republic of China — a moment to cele...
01/10/2026

Celebrating China's National Day🎉

October 1 marks the National Day of the People's Republic of China — a moment to celebrate the country's journey, progress, and achievements.

From China to the world, YHLO continues to grow, innovate, and move forward. 🌐 🚀

Today, we celebrate where we come from, the progress we have made, and the journey still ahead.

Happy National Day of China! 🎊

🔗 Learn more about YHLO: https://en.szyhlo.com

Cardiovascular health is closely connected to every part of our lives, yet many cardiovascular conditions can develop si...
29/09/2026

Cardiovascular health is closely connected to every part of our lives, yet many cardiovascular conditions can develop silently before symptoms become apparent.

On World Heart Day, YHLO stands with healthcare professionals around the world, supporting advances in diagnostic medicine that provide meaningful insights for cardiovascular care. 🌐 🩺

We remain committed to promoting earlier awareness, informed decisions, and better cardiovascular care.

Let's protect every beat—today and every day.

🔗 Learn more about YHLO: https://en.szyhlo.com

Address

YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict
Shenzhen
518000

Telephone

+8675526601910

Website

Alerts

Be the first to know and let us send you an email when YHLO posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to YHLO:

Shortcuts

Share

Category